Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4590493012 | Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen only vaccine product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4590494018 | 2019 novel coronavirus recombinant spike protein antigen vaccine | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4590495017 | SARS-CoV-2 recombinant spike protein antigen vaccine | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 4590497013 | COVID-19 recombinant spike protein antigen vaccine | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 4669634011 | Vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5274031000052117 | vaccin som endast innehåller rekombinant spikeproteinantigen från SARS-CoV-2 | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| SARS-CoV-2 recombinant spike protein antigen vaccine | Is a | SARS-CoV-2 antigen vaccine | true | Inferred relationship | Some | ||
| SARS-CoV-2 recombinant spike protein antigen vaccine | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| SARS-CoV-2 recombinant spike protein antigen vaccine | Has active ingredient | Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Adverse reaction to COVID-19 recombinant spike protein antigen vaccine | Causative agent | True | SARS-CoV-2 recombinant spike protein antigen vaccine | Inferred relationship | Some | 1 |
| Administration of SARS-CoV-2 recombinant spike protein antigen vaccine | Direct substance | True | SARS-CoV-2 recombinant spike protein antigen vaccine | Inferred relationship | Some | 1 |
| Administration of second dose of SARS-CoV-2 recombinant spike protein antigen vaccine | Direct substance | True | SARS-CoV-2 recombinant spike protein antigen vaccine | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR